Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma

Journal of Immunotherapy

Volumn 25, Issue 1, 2002, Pages 16-26

  Sigalotti, Luca ^a   Coral, Sandra ^a   Nardi, Gianpaolo ^a   Spessotto, Alberto ^a   Cortini, Enzo ^a   Cattarossi, Ilaria ^a   Colizzi, Francesca ^a   Altomonte, Maresa ^a   Maio, Michele ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Antigens; Cytosine guanine (CpG) islands; DNA methylation; Immunotherapy; Melanoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CANCER TESTIS ANTIGEN; CYTOSINE; DINUCLEOTIDE; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; GUANINE; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CARCINOGENICITY; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TUMOR CELL;

ANTIGENS, NEOPLASM; AZACITIDINE; DNA METHYLATION; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MELANOMA; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROTEINS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036139334     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200201000-00002     Document Type: Article

References (33)

1. Tumor-antigens recognized by T lymphocytes
2. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
3. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
4. Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine
5. MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte
6. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza2′-deoxycytidine
7. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma
8. NY-ESO-1 may be a potential target for lung cancer immunotherapy
9. Identification of a MAGE2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes
10. Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product
11. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
12. Vaccination with MAGE3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
13. A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells
14. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells
15. Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2′-deoxycytidine (5AZA-CdR)
16. Expression of MAGE genes in primary and metastatic cutaneous melanoma
17. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
18. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
19. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)A2-binding peptide epitopes
20. CTL recognition of an IL-2 producing human melanoma vaccine
21. A modified and improved method for bisulphite based cytosine methylation analysis
22. DNA methylation errors and cancer
23. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
24. DNA methylation is the primary silencing mechanism for a set of germ line- and tumorspecific genes with a CpG-rich promoter
25. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines
26. DNA methylation and gene function
27. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigenspecific vaccination strategies
28. Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
29. Loss of functional beta2-microglobulin in metastatic melanomas from five patients receiving immunotherapy
30. Carcinogenicity and haemoglobin synthesis induction by cytidine analogues
31. DNA methylation and cancer
32. Low-dose 5-aza-2′deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients